Opendata, web and dolomites

UltraEASY

Computer Aided Multispectral Ulstrasound Diagnostic Device

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 UltraEASY project word cloud

Explore the words cloud of the UltraEASY project. It provides you a very rough idea of what is the project "UltraEASY" about.

therewith    daily    continuous    diagnose    patients    risk    monitoring    diagnosing    practices    things    markets    amounts    mobility    diagnostic    health    tissue    eur    family    multispectral    flexibility    diagnosis    multiple    36    final    clinical    beginning    wake    brain    someone    preventatively    regard    basic    stroke    waves    market    units    time    harmful    strategies    helicopters    ultrasound    version    frame    therapeutic    first    feedback    realization    mobile    every    2006    global    interpretable    rescue    ultraeasy    clinics    killing    fast    trade    damage    stands    billion    patient    precise    specialist    suffers    carriers    economic    suited    validation    diagnostics    emergency    neuropathologies    evaluation    frequencies    acquisition    ing    acute    events    innovation    vehicles    medtech    europeans    feasibility    immense    ambulances    sonovum    ag    physicians    camud    conclude    molecular    underlying    thanks    seconds    groups    acoustics    invasive    small    aided    initial    examination    insurance    conduct    vitals    computer    acceptance    incidents    modern   

Project "UltraEASY" data sheet

The following table provides information about the project.

Coordinator
SONOVUM AG 

Organization address
address: PERLICKSTRASSE 5
city: LEIPZIG
postcode: 4103
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Project website http://www.sonovum.de
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.3. (Treating and managing disease)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SONOVUM AG DE (LEIPZIG) coordinator 50˙000.00

Map

 Project objective

Every 40 seconds, someone in Europe suffers from a stroke killing 1,000 Europeans daily. The resulting economic damage is immense. In the 2006 wake-up-study funded by the EU the economic damage in Europe amounts to 36 billion EUR per year. The objective of this project is the clinical validation of SoNovum AG’s UltraEASY™ II Brain Vitals Monitoring System and the underlying CAMUD technology for diagnosing and monitoring neuropathologies in acute events and at-risk patient groups. CAMUD stands for “Computer Aided Multispectral Ultrasound Diagnostics” and is a novel diagnostic method based on molecular acoustics. It measures the feedback of ultrasound waves on multiple frequencies, which is interpretable for the first time thanks to modern computer technology. The technology enables, among other things, a fast, very precise and non-invasive diagnosis of the brain tissue in the beginning of the therapeutic time frame as well as further, continuous monitoring. Therewith physicians will be able to diagnose acute events more quickly and preventatively at-risk patient groups, even before harmful incidents occur. Initial target market groups for UltraEASY II include the stroke units in clinics as well as family and specialist's practices in Europe with regard to global markets as well. Because of high mobility, flexibility and the small acquisition costs, it is well suited as basic equipment for practices as well as, in its mobile version, for helicopters, rescue vehicles and ambulances of clinics and emergency organizations. The objectives of this Feasibility Study are the examination of the market acceptance towards UltraEASY II, addressing clinics and physicians as well as involving patients, patient organizations and health insurance carriers, in order to conduct the risk evaluation for the final realization of the CAMUD technology in the MedTech sector and conclude the development of final innovation strategies for Phase 2.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "ULTRAEASY" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "ULTRAEASY" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.3.)

CLOSER (2019)

Childhood Leukemia: Overcoming distance between South America and Europe Regions

Read More  

GACD (2019)

Global Alliance for Chronic Diseases Secretariat

Read More  

ESCALON (2019)

European-Latin American network for the assessment of biomarkers to predict and diagnose hepatobiliary malignancies and characterization of risk factors for cancer development

Read More